查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
細胞和基因治療製造品質控制 (QC) 市場 - 成長、未來前景、競爭分析，2023-2031 年
市場調查報告書
商品編碼
1422190

細胞和基因治療製造品質控制 (QC) 市場 - 成長、未來前景、競爭分析，2023-2031 年

Cell And Gene Therapy Manufacturing Quality Control (QC) Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

預計 2024 年至 2032 年期間，細胞和基因治療製造品質控制 (QC) 市場將以 25% 的複合年增長率成長。細胞和基因療法生產品質控制 (QC) 在確保細胞和基因療法的安全性、有效性和一致性方面發揮關鍵作用。細胞和基因治療製造品質控制市場是由監管要求、個人化醫療趨勢和分析技術進步所推動的。儘管產品特徵複雜，但由於細胞和基因療法的日益普及，市場有望成長。預計設備和配件以及製程開發領域在預測期內將出現強勁成長。從區域來看，亞太地區有擴張機會。該行業領導者的策略專注於技術整合、產能擴張和全面的品質控制解決方案，以滿足細胞和基因治療製造品質控制不斷變化的需求。

嚴格的監管要求

細胞和基因療法製造品質控制市場是由 FDA 和 EMA 等衛生當局施加的嚴格監管要求所推動的。監管機構要求採取嚴格的品質控制措施，以確保細胞和基因療法符合安全性和有效性標準。例如，FDA 的化學、製造和控制 (CMC) 指南強調徹底的測試、表徵和驗證，以確保治療的品質和一致性。監管環境是品質控制基礎設施和技術投資的關鍵驅動力。

個人化醫療的普及

個人化醫療的興起，即針對個別患者量身定制治療方案，推動了對穩健品質控製程序的需求。細胞和基因療法通常是為每位患者量身定制的，需要精確的表徵、身份確認和功效測試。隨著細胞和基因療法變得更加主流，品質控制市場對先進分析方法和技術的需求激增，以確保特定治療的品質和患者安全。

分析技術的進步

高通量定序、質譜和流式細胞儀等分析技術的快速發展改變了品質控制領域。這些技術能夠對細胞和基因療法進行全面的表徵和分析，包括遺傳組成、純度和效力。將最先進的分析整合到品質控制流程中不僅可以提高治療的品質和可靠性，還可以縮短開發和製造時間。

產品特性的複雜性

細胞和基因治療製造品質控制市場的主要限制因素是產品表徵的複雜性。細胞和基因療法是多方面的，通常包含各種成分，因此難以進行全面的表徵。細胞群、基因修飾和治療機制的異質性需要先進的分析技術來準確評估產品品質。這種複雜性可能會導致更長的品質控制週期和更高的成本。

消耗品按組件佔市場主導地位

A市場依組成部分分為設備/配件、消耗品和其他。2023年，耗材佔據了最高的銷售份額，主要是由於其在細胞治療和基因治療QC流程中的持續使用。預計 2024 年至 2032 年預測期內，設備和配件的複合年增長率最高。先進設備和技術的採用，如下一代定序儀和高性能液相層析系統，預計將推動這一成長。

按工藝分，下游工藝主導市場

市場依製程進一步細分為上游製程、下游製程和製程開發。2023年，下游製程收入最高。這是由於需要純化和分離治療細胞和遺傳物質。然而，預計製程開發將在預測期內實現最高的複合年增長率。專注於優化和擴大製造流程以確保一致的產品品質正在推動對流程開發和相關品質控制策略的投資。

北美仍處於世界領先地位

由於其成熟的細胞和基因治療生態系統、支持性的監管環境以及重要的研發活動，北美在 2023 年佔據了最高的銷售份額。然而，預計 2024 年至 2032 年亞太地區的複合年增長率最高。醫療保健基礎設施投資的增加、研究合作的增加以及合約製造組織 (CMO) 的出現正在推動該地區 QC 市場的成長。

預測期內市場競爭將加劇

細胞和基因治療製造品質控制市場的領先公司包括 Lonza Group、Charles River Laboratories、Eurofins Scientific、WuXiAppTec、bioMA(C)rieux SA、Bio-Rad Laboratories, Inc.、Bio-Techne Corporation、QIAGEN、Merck KGaA、這些包括Intertek Group plc、Thermo Fisher Scientific, Inc. 和F. Hoffmann-La Roche Ltd.。這些公司提供廣泛的品質控制服務、分析工具和專長，以應對細胞和基因治療的獨特挑戰。主要策略包括投資先進的分析技術、擴大測試能力以及提供全面的品質控制解決方案以支援產品開發、製造和法規遵循。該市場的特點是策略聯盟和合作夥伴關係，以滿足不斷變化的品質控制需求。

目錄

第一章 前言

  • 報告內容
    • 報告目的
    • 目標聽眾
    • 主要提供產品
  • 市場細分
  • 調查方法
    • 第一階段—二次調查
    • 第二階段-初步調查
    • 第三階段-專家評審
    • 先決條件
    • 採取的方法

第二章執行摘要

第 3 章 細胞/基因治療製造品質控制 (QC) 市場：競爭分析

  • 主要供應商的市場地位
  • 供應商採取的策略
  • 主要產業戰略
  • 等級分析：2023 年 vs 2032 年

第 4 章 細胞/基因治療製造品質控制 (QC) 市場：宏觀分析與市場動態

  • 介紹
  • 2022-2032 年全球細胞與基因治療製造品質控制 (QC) 市場價值
  • 市場動態
    • 市場驅動力
    • 市場制約因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析
  • 波特的五力模型
    • 供應商實力
    • 購買力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭對手之間的競爭
  • PESTEL 分析
    • 政局
    • 金融情況
    • 技術景觀
    • 法律狀況
    • 社會局勢

第 5 章 細胞和基因治療製造品質控制 (QC) 市場：按組成部分 2022-2032 年

  • 市場概況
  • 成長/利潤分析：2023 年與 2032 年
  • 2022-2032年數量和價格分析
  • 市場細分
    • 設備及配件
    • 消耗品
    • 其他

第 6 章 細胞/基因治療製造品質控制 (QC) 市場：按分析方法 2022-2032

  • 市場概況
  • 成長/利潤分析：2023 年與 2032 年
  • 2022-2032年數量和價格分析
  • 市場細分
    • 無菌測試
    • 純度測試
    • 功效測試
    • 身份測試
    • 其他（穩定性、生存能力等）

第 7 章 細胞/基因治療製造品質控制 (QC) 市場：按流程劃分 2022-2032 年

  • 市場概況
  • 成長/利潤分析：2023 年與 2032 年
  • 2022-2032年數量和價格分析
  • 市場細分
    • 上游工藝
    • 下游工藝
    • 工藝開發

第 8 章 細胞/基因治療製造品質控制 (QC) 市場：按最終用戶劃分 2022-2032 年

  • 市場概況
  • 成長/利潤分析：2023 年與 2032 年
  • 2022-2032年數量和價格分析
  • 市場細分
    • 製藥和生物技術公司
    • 合約製造組織

第9章北美細胞和基因治療製造品質控制（QC）市場2022-2032

  • 市場概況
  • 細胞和基因治療製造品質控制 (QC) 市場：按組成部分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按分析方法 2022-2032
  • 細胞和基因治療製造品質控制 (QC) 市場：按流程劃分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按最終用戶劃分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按地區劃分 2022-2032 年
    • 北美
      • 美國
      • 加拿大
      • 其他北美

第 10 章英國和歐盟細胞和基因治療製造品質控制 (QC) 市場 2022-2032

  • 市場概況
  • 細胞和基因治療製造品質控制 (QC) 市場：按組成部分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按分析方法 2022-2032
  • 細胞和基因治療製造品質控制 (QC) 市場：按流程劃分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按最終用戶劃分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按地區劃分 2022-2032 年
    • 英國和歐盟
      • 英國
      • 德國
      • 西班牙
      • 義大利
      • 法國
      • 歐洲其他地區

第十一章亞太細胞與基因治療製造品質控制 (QC) 市場 2022-2032

  • 市場概況
  • 細胞和基因治療製造品質控制 (QC) 市場：按組成部分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按分析方法 2022-2032
  • 細胞和基因治療製造品質控制 (QC) 市場：按流程劃分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按最終用戶劃分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按地區劃分 2022-2032 年
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 亞太其他地區

第十二章拉丁美洲細胞和基因治療製造品質控制 (QC) 市場 2022-2032

  • 市場概況
  • 細胞和基因治療製造品質控制 (QC) 市場：按組成部分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按分析方法 2022-2032
  • 細胞和基因治療製造品質控制 (QC) 市場：按流程劃分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按最終用戶劃分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按地區劃分 2022-2032 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第十三章中東和非洲細胞和基因治療製造品質控制 (QC) 市場 2022-2032

  • 市場概況
  • 細胞和基因治療製造品質控制 (QC) 市場：按組成部分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按分析方法 2022-2032
  • 細胞和基因治療製造品質控制 (QC) 市場：按流程劃分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按最終用戶劃分 2022-2032 年
  • 細胞和基因治療製造品質控制 (QC) 市場：按地區劃分 2022-2032 年
    • 中東/非洲
      • GCC
      • 非洲
      • 其他中東/非洲地區

第十四章公司簡介

  • Lonza Group
  • Charles River Laboratories
  • Eurofins Scientific
  • WuXiAppTec
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Corporation
  • QIAGEN
  • Merck KGaA
  • Intertek Group plc
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • 其他主要公司
Product Code: 140079-01-24

The cell and gene therapy manufacturing quality control (QC) market is expected to grow at a CAGR of 25% during the forecast period of 2024 to 2032. Cell and gene therapy manufacturing quality control (QC)plays a pivotal role in ensuring the safety, efficacy, and consistency of cell and gene therapies. The cell and gene therapy manufacturing QC market is driven by regulatory requirements, personalized medicine trends, and advancements in analytical technologies. Despite the complexity of product characterization, the market is poised for growth due to the increasing adoption of cell and gene therapies. Equipment and accessories and Process Development segments are expected to exhibit significant growth during the forecast period. Geographically, Asia-Pacific presents opportunities for expansion. Industry leaders' strategies focus on technology integration, capacity expansion, and comprehensive QC solutions to address the evolving demands of cell and gene therapy manufacturing quality control.

Stringent Regulatory Requirements

The QC market for cell and gene therapy manufacturing is driven by stringent regulatory requirements imposed by health authorities such as the FDA and EMA. Regulatory agencies demand rigorous quality control measures to ensure that cell and gene therapies meet safety and efficacy standards. For example, the FDA's guidelines for chemistry, manufacturing, and controls (CMC) emphasize thorough testing, characterization, and validation to ensure the quality and consistency of therapies. The regulatory landscape serves as a significant driver for investments in QC infrastructure and technologies.

Growing Adoption of Personalized Medicine

The rise of personalized medicine, wherein therapies are tailored to individual patients, has amplified the demand for robust QC procedures. Cell and gene therapies are often customized for each patient, requiring precise characterization, identity confirmation, and potency testing. As cell and gene therapies become more mainstream, the QC market experiences a surge in demand for advanced analytical methods and technologies to ensure therapy-specific quality and patient safety.

Advancements in Analytical Technologies

Rapid advancements in analytical technologies, such as high-throughput sequencing, mass spectrometry, and flow cytometry, have revolutionized the QC landscape. These technologies enable comprehensive characterization and analysis of cell and gene therapies, including their genetic makeup, purity, and potency. The integration of cutting-edge analytics into QC processes not only enhances the quality and reliability of therapies but also expedites development and manufacturing timelines.

Complexity of Product Characterization

A key restraint in the cell and gene therapy manufacturing QC market is the complexity of product characterization. Cell and gene therapies are often multifaceted and involve various components, making their comprehensive characterization challenging. The heterogeneity of cell populations, genetic modifications, and therapeutic mechanisms necessitates advanced analytical techniques that can accurately assess product quality. This complexity can lead to prolonged QC timelines and increased costs.

Consumables Dominate the Market by Component

A The market is segmented by component into Equipment and accessories, Consumables, and Others. In 2023, Consumables accounted for the highest revenue share, primarily due to their continuous usage in cell and gene therapy QC processes. During the forecast period from 2024 to 2032, Equipment and accessories are projected to exhibit the highest CAGR. The adoption of advanced equipment and technologies, such as next-generation sequencers and high-performance liquid chromatography systems, is expected to drive this growth.

Downstream Processes Dominate the Market by Process

The market is further segmented by process into Upstream Processes, Downstream Processes, and Process Development. In 2023, Downstream Processes generated the highest revenue, attributed to the need for purification and isolation of therapeutic cells and genetic material. However, during the forecast period, Process Development is anticipated to achieve the highest CAGR. The focus on optimizing and scaling up manufacturing processes to ensure consistent product quality is driving investments in process development and associated QC strategies.

North America Remains as the Global Leader

North America held the highest revenue share in 2023, driven by its established cell and gene therapy ecosystem, supportive regulatory environment, and significant research and development activities. However, the Asia-Pacific region is projected to witness the highest CAGR from 2024 to 2032. Increasing investments in healthcare infrastructure, rising research collaborations, and the emergence of contract manufacturing organizations (CMOs) are driving the growth of the QC market in this region.

Market Competition to Intensify during the Forecast Period

Prominent players in the cell and gene therapy manufacturing QC market include Lonza Group, Charles River Laboratories, Eurofins Scientific, WuXiAppTec, bioMA©rieux SA, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, QIAGEN, Merck KGaA, Intertek Group plc, Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd. These companies provide a wide array of QC services, analytical tools, and expertise tailored to the unique challenges of cell and gene therapies. Key strategies involve investing in advanced analytical technologies, expanding testing capabilities, and offering comprehensive QC solutions that support product development, manufacturing, and regulatory compliance. The market is characterized by strategic collaborations and partnerships to address evolving QC needs.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofCell And Gene Therapy Manufacturing Quality Control (QC) market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Cell And Gene Therapy Manufacturing Quality Control (QC) market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Component

    • Equipment & Accessories
    • Consumables
    • Others

Analytical Method

    • Sterility Testing
    • Purity Testing
    • Potency Testing
    • Identity Testing
    • Others (stability, viability, etc.)

Process

    • Upstream Processes
    • Downstream Processes
    • Process Development

End-User

    • Pharmaceutical & Biotechnology Companies
    • Contract Manufacturing Organizations

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • Which is the largest regional market for Cell And Gene Therapy Manufacturing Quality Control (QC) market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Cell And Gene Therapy Manufacturing Quality Control (QC) market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Cell And Gene Therapy Manufacturing Quality Control (QC) market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market
  • 2.2. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023 (US$ Million)
  • 2.3. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023 (US$ Million)
  • 2.4. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023 (US$ Million)
  • 2.5. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023 (US$ Million)
  • 2.6. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Geography, 2023 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2023

3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Competitive Analysis

  • 3.1. Market Positioning of Key Cell And Gene Therapy Manufacturing Quality Control (QC) Market Vendors
  • 3.2. Strategies Adopted by Cell And Gene Therapy Manufacturing Quality Control (QC) Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Volume and Pricing Analysis, 2022-2032
  • 5.4. Market Segmentation
    • 5.4.1. Equipment & Accessories
    • 5.4.2. Consumables
    • 5.4.3. Others

6. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Volume and Pricing Analysis, 2022-2032
  • 6.4. Market Segmentation
    • 6.4.1. Sterility Testing
    • 6.4.2. Purity Testing
    • 6.4.3. Potency Testing
    • 6.4.4. Identity Testing
    • 6.4.5. Others (stability, viability, etc.)

7. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Volume and Pricing Analysis, 2022-2032
  • 7.4. Market Segmentation
    • 7.4.1. Upstream Processes
    • 7.4.2. Downstream Processes
    • 7.4.3. Process Development

8. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 8.3. Volume and Pricing Analysis, 2022-2032
  • 8.4. Market Segmentation
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Contract Manufacturing Organizations

9. North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 9.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 9.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 9.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 9.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 9.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 9.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 9.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 9.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 9.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 9.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 9.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 9.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 9.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

10. UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 10.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 10.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 10.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 10.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.4.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.4.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.4.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.5.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.5.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.5.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 10.6.1.6.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 10.6.1.6.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 10.6.1.6.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

11. Asia Pacific Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 11.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 11.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 11.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 11.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.4.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.4.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.4.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.5.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.5.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.5.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 11.6.1.6.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 11.6.1.6.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 11.6.1.6.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

12. Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 12.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 12.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 12.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 12.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 12.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 12.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 12.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 12.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 12.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 12.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 12.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 12.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 12.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

13. Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)

  • 13.1. Market Overview
  • 13.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
  • 13.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
  • 13.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
  • 13.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
  • 13.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 13.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 13.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 13.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 13.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 13.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 13.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
        • 13.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
        • 13.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
        • 13.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

14. Company Profile

  • 14.1. Lonza Group
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Charles River Laboratories
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Eurofins Scientific
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. WuXiAppTec
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. bioMerieux SA
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Bio-Rad Laboratories, Inc.
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Bio-Techne Corporation
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. QIAGEN
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Merck KGaA
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Intertek Group plc
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. Thermo Fisher Scientific, Inc.
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. F. Hoffmann-La Roche Ltd.
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives
  • 14.13. Other Notable Players
    • 14.13.1. Company Overview
    • 14.13.2. Financial Performance
    • 14.13.3. Product Portfolio
    • 14.13.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 2 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 3 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 4 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 5 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 6 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 7 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 8 North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 9 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 10 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 11 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 12 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 13 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 14 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 15 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 16 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 17 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 18 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 19 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 20 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 21 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 22 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 23 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 24 UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 25 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 26 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 27 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 28 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 29 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 30 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 31 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 32 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 33 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 34 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 35 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 36 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 37 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 38 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 39 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 40 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 41 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 42 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 43 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 44 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 45 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 46 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 47 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 48 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 49 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 50 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 51 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 52 Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 53 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 54 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 55 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 56 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 57 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 58 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 59 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 60 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 61 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 62 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 63 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 64 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 65 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 66 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 67 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 68 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 69 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 70 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 71 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 72 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 73 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 74 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 75 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 76 Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 77 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 78 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 79 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 80 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 81 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 82 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 83 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 84 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 85 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 86 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 87 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 88 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 89 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 90 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 91 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 92 Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 93 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 94 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 95 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 96 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 97 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 98 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 99 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 100 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Component, 2022-2032, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Analytical Method, 2022-2032, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By Process, 2022-2032, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market By End-User, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Quality Assurance
  • FIG. 5 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023
  • FIG. 6 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023
  • FIG. 7 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023
  • FIG. 8 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023
  • FIG. 9 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Geography, 2023
  • FIG. 10 Market Geographical Opportunity Matrix - Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2023

FIG. 11Market Positioning of Key Cell And Gene Therapy Manufacturing Quality Control (QC) Market Players, 2023

FIG. 12Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 13 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023 Vs 2032, %
  • FIG. 14 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023 Vs 2032, %
  • FIG. 15 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023 Vs 2032, %
  • FIG. 16 Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023 Vs 2032, %
  • FIG. 17 U.S. Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 18 Canada Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 19 Rest of North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 20 UK Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 21 Germany Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 22 Spain Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 23 Italy Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 24 France Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 25 Rest of Europe Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 26 China Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 27 Japan Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 28 India Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 29 Australia Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 30 South Korea Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 31 Rest of Asia Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 32 Brazil Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 33 Mexico Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 34 Rest of Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 35 GCC Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 36 Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032
  • FIG. 37 Rest of Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market (US$ Million), 2022 - 2032